Day 1, Morning Session

Day 1, Afternoon Session

Day 1, Plenary Session

Learning from the Field: Concrete Lessons from Pilot Projects on Genomic Newborn Screening

1. (Moderator) Laurence Faivre, CHU Dijon France

2. Robert Green, Harvard Medical School - Lessons learned from BabySeq

3. Wendy Chung, Boston Children’s Hospital - Lessons learned from GUARDIAN

4. David Bick, Genomics England - Lessons learned from Generation Study

5. Sebastian Lunke, The Royal Children’s Hospital - Lessons learned from BabyScreen

6. Laurent Servais, CHU Liège - Lessons learned from BabyDetect

Day 2, Morning Session

Valuing genomic newborn sequencing: an educational session for non health economists

Presenters:

1. (Moderator) James Buchanan, Queen Mary University of London, - Challenges when estimating value in the context of genomic newborn sequencing

2. Martin Vu, Queen Mary University of London - An introduction to economic evaluation for non health economists

3. Miranda Bailey, Rocket Pharmaceuticals - Current evidence on the value of genomics

4. Hadley Stevens Smith, Harvard University - Determining value when an intervention impacts multiple conditions simultaneously: An example from the BabySeq Project

5. Aditi Satija, Genomics England - Determining value when an intervention impacts multiple conditions simultaneously: An example from the Generation Study

Day 2, Afternoon Session

Public health impacts of genomic newborn sequencing

Presenters:

1. (Moderator) Emma Baple, University of Exeter

2. Dr. Anne Mackie, UK National Screening Committee - Public health considerations in population screening – a UK perspective

3. Prof. Martina Cornel, Amsterdam University Medical Center, Netherlands Health Council (specifically Population Screening and Council Group committees) - Public health considerations in population screening – a European perspective

4. Dr. Amicia Phillips, University of Exeter - Defining actionability within an expanded newborn genome screening context

5. Dr. David Bick, Genomics England - Readying health systems to handle expanded newborn genome screening

6. Dr. Aimé Lumaka, University of Kinshasa - Public health considerations in population screening - a African perspective